of AMENDMENT of
THERAPEUTICS, INC. (the “Corporation”) a corporation organized and existing under
and by virtue of the Delaware General Corporation Law (“DGCL”) does hereby certify:
the Board of Directors of the Corporation, by the unanimous written consent of its Directors, filed with the minutes of
the Board, adopted a resolution proposing and declaring advisable the following amendment
to the Certificate of Incorporation of the Corporation:
that the Certificate of Incorporation of this Corporation be amended by changing
the Article thereof numbered “One”, so that, as amended, said Article shall be and read, in pertinent part,
The name of the corporation is Q Therapeutic Products, Inc. (the “Corporation”).
That in lieu of a meeting and vote of the stockholders of the Corporation, a majority of the holders of the Corporation’s
Common Stock have given their written consent to said amendment in accordance with
the provisions of Section 228 of the DGCL, and written notice of the adoption of
the amendment has been given as provided in Section 228 of the DGCL to every stockholder entitled to such notice.
the foregoing amendment of the Certificate of Incorporation was duly adopted in accordance with the provisions of Section
242 of the DGCL.
This Amendment shall be effective upon filing.
WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be executed on this 9th day of
||Q THERAPEUTICS, INC.|
||/s/ Deborah A. Eppstein|
||Deborah A. Eppstein, PhD.|
||President and CEO|